<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">101726364</journal-id><journal-id journal-id-type="pubmed-jr-id">47540</journal-id><journal-id journal-id-type="nlm-ta">Genom Comput Biol</journal-id><journal-id journal-id-type="iso-abbrev">Genom Comput Biol</journal-id><journal-title-group><journal-title>Genomics and computational biology</journal-title></journal-title-group><issn pub-type="epub">2365-7154</issn></journal-meta><article-meta><article-id pub-id-type="pmid">29951575</article-id><article-id pub-id-type="pmc">6016388</article-id><article-id pub-id-type="doi">10.18547/gcb.2018.vol4.iss1.e100050</article-id><article-id pub-id-type="manuscript">NIHMS962615</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Computational Systems Biology Approach for the Study of Rheumatoid Arthritis: From a Molecular Map to a Dynamical Model</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Singh</surname><given-names>Vidisha</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ostaszewski</surname><given-names>Marek</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Kalliolias</surname><given-names>George D.</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Chiocchia</surname><given-names>Gilles</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Olaso</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Petit-Teixeira</surname><given-names>Elisabeth</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Helikar</surname><given-names>Tom&#x000e1;&#x00161;</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Niarakis</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="author-notes" rid="FN1">*</xref></contrib></contrib-group><aff id="A1">
<label>1</label>GenHotel EA3886, Univ Evry, Universit&#x000e9; Paris-Saclay, 91025, Evry, France</aff><aff id="A2">
<label>2</label>Luxembourg Centre for Systems Biomedicine, Universit&#x000e9; du Luxembourg, Esch-sur-Alzette, Luxembourg</aff><aff id="A3">
<label>3</label>Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, USA; Department of Medicine, Weill Cornell Medical College, New York City, USA</aff><aff id="A4">
<label>4</label>Faculty of Health Sciences Simone Veil, INSERM U1173, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France</aff><aff id="A5">
<label>5</label>Centre National de Recherche en G&#x000e9;nomique Humaine (CNRGH), CEA, Evry, France</aff><aff id="A6">
<label>6</label>Department of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE, USA</aff><author-notes><corresp id="FN1"><label>*</label>Correspondence: <email>anna.niaraki@univ-evry.fr</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>6</day><month>5</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>6</day><month>12</month><year>2017</year></pub-date><pub-date pub-type="ppub"><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>6</month><year>2018</year></pub-date><volume>4</volume><issue>1</issue><elocation-id>e100050</elocation-id><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><title>SUMMARY</title><p id="P1">In this work we present a systematic effort to summarize current biological pathway knowledge concerning Rheumatoid Arthritis (RA). We are constructing a detailed molecular map based on exhaustive literature scanning, strict curation criteria, re-evaluation of previously published attempts and most importantly experts&#x02019; advice. The RA map will be web-published in the coming months in the form of an interactive map, using the MINERVA platform, allowing for easy access, navigation and search of all molecular pathways implicated in RA, serving thus, as an on line knowledgebase for the disease. Moreover the map could be used as a template for Omics data visualization offering a first insight about the pathways affected in different experimental datasets. The second goal of the project is a dynamical study focused on synovial fibroblasts&#x02019; behavior under different initial conditions specific to RA, as recent studies have shown that synovial fibroblasts play a crucial role in driving the persistent, destructive characteristics of the disease. Leaning on the RA knowledgebase and using the web platform Cell Collective, we are currently building a Boolean large scale dynamical model for the study of RA fibroblasts&#x02019; activation.</p></abstract><kwd-group><kwd>Complex human disease</kwd><kwd>Rheumatoid arthritis</kwd><kwd>Computational systems biology</kwd><kwd>Interactive molecular map</kwd><kwd>Signaling network</kwd><kwd>Dynamical modelling</kwd></kwd-group></article-meta></front><body><p id="P2">Protein-protein interactions are a major driving force behind most biological processes. They play a pivotal role in intra- and extra-cellular functions, and especially in the propagation of signals and cellular regulation. Signal transduction is a fundamental process for the communication of the cell with its environment, comprising several interacting receptors, proteins, enzymes, second messengers and transcription factors. Disruption and dysregulation of these complex molecular and signaling networks can lead to disease. Therefore, the mapping and accurate representation of pathways implicated is a primary but essential step for elucidating the mechanisms underlying disease pathogenesis.</p><p id="P3">The release of various molecular maps dealing with obesity [<xref rid="R1" ref-type="bibr">1</xref>], gastrin and cholecystokinin receptors signaling [<xref rid="R2" ref-type="bibr">2</xref>], FceRI receptor signaling in allergy [<xref rid="R3" ref-type="bibr">3</xref>], MAPKs [<xref rid="R4" ref-type="bibr">4</xref>], mTOR signaling [<xref rid="R5" ref-type="bibr">5</xref>] to name a few, corroborates the fact that pathway assembly in the form of network is gaining ground in systems biology. As more scientists invest time and effort to construct large molecular networks, there is an increasing need for practical guidelines and a standardized framework. Toward this direction, initiatives have emerge, such as The Cancer Cell Map Initiative [<xref rid="R6" ref-type="bibr">6</xref>], the Atlas of Cancer Signaling Networks (<ext-link ext-link-type="uri" xlink:href="http://acsn.curie.fr">http://acsn.curie.fr</ext-link>) concerning cancer, and the Disease Maps Project (<ext-link ext-link-type="uri" xlink:href="http://disease-maps.org">http://disease-maps.org</ext-link>), an open, large-scale community effort that consists of a network of groups working together for developing best practices, standards and tools in order to better represent disease mechanisms.</p><p id="P4">However, as all living systems are dynamic in nature, static representations of molecular networks can provide useful but relatively limited understanding. A dynamical study can reveal information about the system&#x02019;s behavior under different conditions by <italic>in silico</italic> simulations, perturbations, hypotheses testing and predictions. Quantitative kinetic modelling approaches using differential or stochastic equations can provide a detailed analysis of a network&#x02019;s dynamics, but the large number of parameters required make them less appropriate for large scale signaling networks. In order to address the lack of kinetic data, discrete logical modelling can be used as an alternative way to study the system&#x02019;s qualitative dynamic behavior [<xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R8" ref-type="bibr">8</xref>].</p><p id="P5">In this work we present a systematic effort to summarize current biological pathway knowledge concerning Rheumatoid Arthritis (RA), a multifactorial autoimmune disease that causes chronic inflammation of the synovial joints with an etiology that still remains unclear. With the use of the software CellDesigner [<xref rid="R9" ref-type="bibr">9</xref>], we are constructing a detailed molecular map based on exhaustive literature scanning, strict curation criteria, re-evaluation of previously published attempts [<xref rid="R10" ref-type="bibr">10</xref>] and most importantly experts&#x02019; advice (<xref rid="F1" ref-type="fig">Figure 1</xref>).</p><p id="P6">In 2010 Wu <italic>et al.</italic> published a detailed molecular map concerning rheumatoid arthritis using the software CellDesigner. We decided to use this map as a basis, and expand. The map has been updated with information published after 2010 by exhaustive manual curation and the help of data mining tools. Only experimentally validated interactions in at least two peer reviewed scientific publications are kept. Due to the fact that the initial map was based on high throughput gene expression data from 28 studies and interactions inferred from KEGG database, all nodes and interactions are re-evaluated carefully in an effort to limit false positives. When validation with small scale experiments is not possible, we keep nodes that appear in at least two different high throughput studies. Detailed annotation including PubMED IDs and HUGO names is also added in the MIRIAM section of the CellDesigner file. As far as context representation and overall structure of the map, expert&#x02019;s advice has been taken into account along with an effort to comply with SBGN standards.</p><p id="P7">The RA map will be web-published in the coming months (a full length manuscript is under preparation) in the form of an interactive map, using the platform MINERVA [<xref rid="R11" ref-type="bibr">11</xref>], allowing for easy access, navigation and search of all molecular pathways implicated in RA, serving thus, as an on line knowledge base for the disease. The user will have access to all literature used, with detailed annotations for every component and reaction, including PubMed IDs, and a list of identifiers such as Uniprot, EntrezGene, Ensembl, HGNC and RefSeq. As the map is constructed using information from various experimental studies, the user will also be able to opt for visualization of data with specific cell origin, highlighting cell-specific sub-networks within the global one. Moreover, the user will have the possibility to spot all known drug targets, and the corresponding drugs up to date for RA. Detailed view of an element will allow the search for drugs, chemicals and miRNAs targeting this particular element. Additionally, user-provided omic datasets could be displayed as overlay, giving a first estimation of affected pathways and components. Lastly, the map will provide feedback about the unmapped molecules from the dataset, allowing for better understanding of the experimental results and for further development of the map&#x02019;s contents. We have used public datasets from proteomic and transcriptomic studies [<xref rid="R12" ref-type="bibr">12</xref>&#x02013;<xref rid="R14" ref-type="bibr">14</xref>] to demonstrate how the map can be used as a template for separate or simultaneous visualization of different experimental results. The map will also be used for the mapping of in-house data concerning the transcriptome analysis of ten individuals that developed RA (measurements before the onset of the disease and early after) (Teixeira <italic>et al</italic>., under preparation).</p><p id="P8">The RA map so far includes information derived from more than 100 scientific papers. It has six distinct compartments, namely extracellular space (with extracellular proteins), plasma membrane (with membrane receptors and ligand proteins), cytoplasm (with proteins, miRNAs, small molecules and the sub-compartments of mitochondrion, Golgi apparatus and endoplasmic reticulum), nucleus (with genes, RNAs and transcription factors), a compartment for the secreted molecules and a phenotype compartment including more than ten cellular fates. It comprises more than 400 components and a total of 324 reactions. Each component and reaction in the map is referenced with at least two PubMed IDs or database identifiers if inferred from a specific database.</p><p id="P9">Topological analysis of the RA map using the software Cytoscape [<xref rid="R15" ref-type="bibr">15</xref>] and relevant plugins reveals unconnected or loosely connected parts that reflect our fragmented knowledge about physical and/or genetic interactions, posing thus obstacles in the subsequent derivation of a reliable dynamical model. To improve connectivity we use dedicated PPI databases (through <ext-link ext-link-type="uri" xlink:href="http://www.imexconsortium.org">http://www.imexconsortium.org</ext-link>), pathway databases (e.g. KEGG, SIGNOR or REACTOME) and the commercial software Ingenuity Pathway Analysis (IPA, <ext-link ext-link-type="uri" xlink:href="http://www.ingenuity.com">http://www.ingenuity.com</ext-link>) in order to investigate potential co-players of the proteins of interest. For the time being, we do not make use of simulated/computationally inferred interactions or interactions inferred from other species (i.e. mice), restricting our search to experimentally validated data of human origin.</p><p id="P10">Characteristic features of RA include synovial inflammation that can lead to bone erosion and permanent deformity. It is broadly recognized that in RA, synovial inflammation results from complex interactions between haematopoietic and stromal cells. Recent studies have shown that RA synovial fibroblasts play a crucial role in driving the persistent, destructive characteristics of the disease [<xref rid="R16" ref-type="bibr">16</xref>].</p><p id="P11">The second scope of the project is to model synovial fibroblasts behavior under different initial conditions specific to RA, in order to see if we could influence the cellular fate (e.g. enhancing an apoptotic phenotype) or understand what could lead to patient&#x02019;s resistance to a certain drug and how to overcome it (e.g. presence of rescue pathways, complex feedback mechanisms).</p><p id="P12">In general, pathway representation and modelling can be seen as two separate tasks with different primary objectives. The first is to draw an accurate, comprehensive diagram depicting current biological knowledge while the second is to study the emergent behavior of the system under different conditions. However, a detailed, fully annotated molecular map works as an excellent scaffold for the building of a regulatory graph and the subsequent derivation of the logical model. This process, that involves many iterations, obliges one to look meticulously into the mapped pathways, spotting potentially problematic or ambiguous aspects of the map. Model simulations can also reveal inconsistencies concerning the global behavior, advocating the necessity for further revisions and refinements. Leaning on the RA knowledge base and using the web platform Cell Collective [<xref rid="R17" ref-type="bibr">17</xref>], we are currently building a Boolean dynamical model for the study of RA fibroblasts&#x02019; activation. The model is based on a previously published, more generic model on fibroblasts [<xref rid="R18" ref-type="bibr">18</xref>] that is being modified accordingly in order to be RA specific.</p><p id="P13">In Boolean formalism, nodes represent regulatory components (proteins, complexes, transcription factors, etc.) and arcs represent their interactions. Each regulatory component is associated with a Boolean variable (taking the values 0 or 1) denoting its qualitative concentration or level of activity (0 for absent or inactive, 1 for present or active). The future state of each node depends on the states of its upstream regulators and is defined by a Boolean function, expressed in the form of a rule using the logical operators AND, OR and NOT.</p><p id="P14">The tuning of the model includes testing against published data and appropriate modifications of logical rules and/or addition/deletion of interactions/components until it is able to reproduce well established input-output relations (global behavior). This process will inevitably lead back to the re-evaluation of the molecular map and further discussions with experts until all issues are resolved in a biologically sound way. The model will then be used to systematically test different initial conditions and stimuli (presence or absence of different cytokines and growth factors, and their combinations). The aim is to predict the system&#x02019;s response to single or combined perturbations, and identify novel targets for pharmacological intervention.</p><p id="P15">The Boolean model will be made publicly available in Cell Collective for further contributions, simulations, and analyses by the research community, hopefully within 2018. The web based platform Cell Collective allows real time simulations without the need for software installation making the model more accessible to a wider audience. Moreover, the platform supports annotation, so the user can have simultaneous access to the model description, the rules and the literature used for the rules&#x02019; inference.</p><p id="P16">Lastly, the resulting logical model for RA fibroblasts could be further analyzed with the software GINsim [<xref rid="R19" ref-type="bibr">19</xref>] and also serve as a template for the derivation of a continuous model using the software MaBoSS [<xref rid="R20" ref-type="bibr">20</xref>] allowing the computation of phenotype probabilities.</p></body><back><fn-group><fn fn-type="COI-statement" id="FN2"><p><bold>CONFLICT OF INTEREST</bold></p><p>The authors declare no conflict of interest.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jagannadham</surname><given-names>J</given-names></name><name><surname>Jaiswal</surname><given-names>HK</given-names></name><name><surname>Agrawal</surname><given-names>S</given-names></name><name><surname>Rawal</surname><given-names>K</given-names></name></person-group><article-title>Comprehensive Map of Molecules Implicated in Obesity</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><issue>2</issue><fpage>e0146759</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0146759</pub-id><pub-id pub-id-type="pmid">26886906</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>S</given-names></name><name><surname>Flobak</surname><given-names>&#x000c5;</given-names></name><name><surname>Chawla</surname><given-names>K</given-names></name><name><surname>Baudot</surname><given-names>A</given-names></name><name><surname>Bruland</surname><given-names>T</given-names></name><name><surname>Thommesen</surname><given-names>L</given-names></name><etal/></person-group><article-title>The gastrin and cholecystokinin receptors mediated signaling network: a scaffold for data analysis and new hypotheses on regulatory mechanisms</article-title><source>BMC Systems Biology</source><year>2015</year><volume>9</volume><fpage>40</fpage><pub-id pub-id-type="doi">10.1186/s12918-015-0181-z</pub-id><pub-id pub-id-type="pmid">26205660</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niarakis</surname><given-names>A</given-names></name><name><surname>Bounab</surname><given-names>Y</given-names></name><name><surname>Grieco</surname><given-names>L</given-names></name><name><surname>Roncagalli</surname><given-names>R</given-names></name><name><surname>Hesse</surname><given-names>AM</given-names></name><name><surname>G</surname><given-names>J</given-names></name><etal/></person-group><article-title>Computational modeling of the main signaling pathways involved in mast cell activation</article-title><source>Curr Top Microbiol Immunol</source><year>2014</year><volume>382</volume><fpage>69</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-07911-04</pub-id><pub-id pub-id-type="pmid">25116096</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grieco</surname><given-names>L</given-names></name><name><surname>Calzone</surname><given-names>L</given-names></name><name><surname>Bernard-Pierrot</surname><given-names>I</given-names></name><name><surname>Radvanyi</surname><given-names>F</given-names></name><name><surname>Kahn-Perl&#x000e8;s</surname><given-names>B</given-names></name><name><surname>Thieffry</surname><given-names>D</given-names></name></person-group><article-title>Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision</article-title><source>PLoS Computational Biology</source><year>2013</year><volume>9</volume><issue>10</issue><fpage>e1003286</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003286</pub-id><pub-id pub-id-type="pmid">24250280</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caron</surname><given-names>E</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Matsuoka</surname><given-names>Y</given-names></name><name><surname>Ashton-Beaucage</surname><given-names>D</given-names></name><name><surname>Therrien</surname><given-names>M</given-names></name><name><surname>Lemieux</surname><given-names>S</given-names></name><etal/></person-group><article-title>A comprehensive map of the mTOR signaling network</article-title><source>Molecular Systems Biology</source><year>2010</year><volume>6</volume><fpage>453</fpage><pub-id pub-id-type="doi">10.1038/msb.2010.108</pub-id><pub-id pub-id-type="pmid">21179025</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krogan</surname><given-names>NJ</given-names></name><name><surname>Lippman</surname><given-names>S</given-names></name><name><surname>Agard</surname><given-names>DA</given-names></name><name><surname>Ashworth</surname><given-names>A</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name></person-group><article-title>The Cancer Cell Map Initiative: Defining the Hallmark Networks of Cancer</article-title><source>Molecular Cell</source><year>2015</year><volume>58</volume><issue>4</issue><fpage>690</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.05.008</pub-id><pub-id pub-id-type="pmid">26000852</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wynn</surname><given-names>ML</given-names></name><name><surname>Consul</surname><given-names>N</given-names></name><name><surname>Merajver</surname><given-names>SD</given-names></name><name><surname>Schnell</surname><given-names>S</given-names></name></person-group><article-title>Logic-based models in systems biology: a predictive and parameter-free network analysis method</article-title><source>Integrative Biology</source><year>2012</year><volume>4</volume><issue>11</issue><pub-id pub-id-type="doi">10.1039/c2ib20193c</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abou-Jaoud&#x000e9;</surname><given-names>W</given-names></name><name><surname>Traynard</surname><given-names>P</given-names></name><name><surname>Monteiro</surname><given-names>PT</given-names></name><name><surname>Saez-Rodriguez</surname><given-names>J</given-names></name><name><surname>Helikar</surname><given-names>T</given-names></name><name><surname>Thieffry</surname><given-names>D</given-names></name><etal/></person-group><article-title>Logical Modeling and Dynamical Analysis of Cellular Networks</article-title><source>Frontiers in Genetics</source><year>2016</year><volume>7</volume><fpage>94</fpage><pub-id pub-id-type="doi">10.3389/fgene.2016.00094</pub-id><pub-id pub-id-type="pmid">27303434</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funahashi</surname><given-names>A</given-names></name><name><surname>Morohashi</surname><given-names>M</given-names></name><name><surname>Kitano</surname><given-names>H</given-names></name></person-group><article-title>CellDesigner:a process diagram editor for gene-regulatory and biochemical networks</article-title><source>Biosilico</source><year>2003</year><volume>1</volume><issue>5</issue><fpage>159</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/S1478-5382(03)02370-9</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Dent</surname><given-names>JE</given-names></name><name><surname>Nardini</surname><given-names>C</given-names></name></person-group><article-title>A Comprehensive Molecular Interaction Map for Rheumatoid Arthritis</article-title><source>PLOS ONE</source><year>2010</year><comment>04</comment><volume>5</volume><issue>4</issue><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0010137</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gawron</surname><given-names>P</given-names></name><name><surname>Ostaszewski</surname><given-names>M</given-names></name><name><surname>Satagopam</surname><given-names>V</given-names></name><name><surname>Gebel</surname><given-names>S</given-names></name><name><surname>Mazein</surname><given-names>A</given-names></name><name><surname>Kuzma</surname><given-names>M</given-names></name><etal/></person-group><article-title>MINERVA&#x02014;a platform for visualization and curation of molecular interaction network</article-title><source>npj Systems Biology and Applications</source><year>2016</year><volume>2</volume><fpage>16020</fpage><pub-id pub-id-type="doi">10.1038/npjsba.2016.20</pub-id><pub-id pub-id-type="pmid">28725475</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasuri</surname><given-names>K</given-names></name><name><surname>Antonovici</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Wong</surname><given-names>K</given-names></name><name><surname>Standing</surname><given-names>K</given-names></name><name><surname>Ens</surname><given-names>W</given-names></name><etal/></person-group><article-title>The synovial proteome: analysis of fibroblast-like synoviocytes</article-title><source>Arthritis Research and Therapy</source><year>2004</year><volume>6</volume><issue>2</issue><fpage>R161</fpage><pub-id pub-id-type="doi">10.1186/ar1153</pub-id><pub-id pub-id-type="pmid">15059280</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teixeira</surname><given-names>VH</given-names></name><name><surname>Olaso</surname><given-names>R</given-names></name><name><surname>Martin-Magniette</surname><given-names>ML</given-names></name><name><surname>Lasbleiz</surname><given-names>S</given-names></name><name><surname>Jacq</surname><given-names>L</given-names></name><name><surname>Oliveira</surname><given-names>CR</given-names></name><etal/></person-group><article-title>Transcriptome Analysis Describing New Immunity and Defense Genes in Peripheral Blood Mononuclear Cells of Rheumatoid Arthritis Patients</article-title><source>PLoS ONE</source><year>2009</year><volume>4</volume><issue>8</issue><fpage>0006803</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0006803</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heruth</surname><given-names>DP</given-names></name><name><surname>Gibson</surname><given-names>M</given-names></name><name><surname>Grigoryev</surname><given-names>DN</given-names></name><name><surname>Zhang</surname><given-names>LQ</given-names></name><name><surname>Ye</surname><given-names>SQ</given-names></name></person-group><article-title>RNA-seq analysis of synovial fibroblasts brings new insights into rheumatoid arthritis</article-title><source>Cell and bioscience</source><year>2012</year><volume>2</volume><issue>1</issue><fpage>43</fpage><pub-id pub-id-type="doi">10.1186/2045-3701-2-43</pub-id><pub-id pub-id-type="pmid">23259760</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname><given-names>P</given-names></name><name><surname>Markiel</surname><given-names>A</given-names></name><name><surname>Ozier</surname><given-names>O</given-names></name><name><surname>Baliga</surname><given-names>NS</given-names></name><name><surname>Wang</surname><given-names>JT</given-names></name><name><surname>Ramage</surname><given-names>D</given-names></name><etal/></person-group><article-title>Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks</article-title><source>Genome Research</source><year>2003</year><volume>13</volume><issue>11</issue><fpage>2498</fpage><lpage>2504</lpage><pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id><pub-id pub-id-type="pmid">14597658</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juarez</surname><given-names>M</given-names></name><name><surname>Filer</surname><given-names>A</given-names></name><name><surname>Buckley</surname><given-names>C</given-names></name></person-group><article-title>Fibroblasts as therapeutic targets in rheumatoid arthritis and cancer</article-title><source>Swiss Medical Weekly</source><year>2012</year><volume>142</volume><fpage>w13529</fpage><pub-id pub-id-type="doi">10.4414/smw.2012.13529</pub-id><pub-id pub-id-type="pmid">22367980</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helikar</surname><given-names>T</given-names></name><name><surname>Kowal</surname><given-names>B</given-names></name><name><surname>McClenathan</surname><given-names>S</given-names></name><name><surname>Bruckner</surname><given-names>M</given-names></name><name><surname>Rowley</surname><given-names>T</given-names></name><name><surname>Madrahimon</surname><given-names>A</given-names></name><etal/></person-group><article-title>The Cell Collective: Toward an open and collaborative approach to systems biology</article-title><source>BMC Systems Biology</source><year>2012</year><volume>6</volume><issue>96</issue><pub-id pub-id-type="doi">10.1186/1752-0509-6-96</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helikar</surname><given-names>T</given-names></name><name><surname>Konvalina</surname><given-names>J</given-names></name><name><surname>Heidel</surname><given-names>J</given-names></name><name><surname>Rogers</surname><given-names>JA</given-names></name></person-group><article-title>Emergent decision-making in biological signal transduction networks</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2008</year><volume>105</volume><issue>6</issue><fpage>1913</fpage><lpage>1918</lpage><pub-id pub-id-type="doi">10.1073/pnas.0705088105</pub-id><pub-id pub-id-type="pmid">18250321</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chaouiya</surname><given-names>C</given-names></name><name><surname>Naldi</surname><given-names>A</given-names></name><name><surname>Thieffry</surname><given-names>D</given-names></name><collab>Logical Modelling of Gene Regulatory Networks with GINsim</collab></person-group><source>Bacterial Molecular Networks: Methods and Protocols</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Springer New York</publisher-name><year>2012</year><fpage>463</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1007/978-1-61779-361-523</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoll</surname><given-names>G</given-names></name><name><surname>Caron</surname><given-names>B</given-names></name><name><surname>Viara</surname><given-names>E</given-names></name><name><surname>Dugourd</surname><given-names>A</given-names></name><name><surname>Zinovyev</surname><given-names>A</given-names></name><name><surname>Naldi</surname><given-names>A</given-names></name><etal/></person-group><article-title>MaBoSS 2.0: an environment for stochastic Boolean modeling</article-title><source>Bioinformatics</source><year>2017</year><volume>33</volume><issue>14</issue><fpage>2226</fpage><lpage>2228</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btx123</pub-id><pub-id pub-id-type="pmid">28881959</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Data integration workflow</title><p>The building of a logical model is an iterative multistep process. The assembly of a molecular map comprising biological pathways of interest and integrating information from literature and public databases could serve as the first step. Experts&#x02019; feedback assures the quality of the map and the accuracy of the knowledge represented, along with strict curation criteria and standards for the graphical representation. Web publication facilitates community feedback and transforms the map in a powerful data analysis and visualization tool. The network can be further exploited using graph analysis tools to identify important nodes and pathways, or it can serve as a scaffold for dynamical models allowing simulations. Interesting predictions can then be experimentally tested, contributing to the validation and refinement of the map. Regular revisions are also necessary to ensure the incorporation of novel data (Figure adapted from Niarakis <italic>et al.</italic>, 2014 [<xref rid="R3" ref-type="bibr">3</xref>]).</p></caption><graphic xlink:href="nihms962615f1"/></fig></floats-group></article>